Podcasts about Obesity

Gary Brecka is a human biologist, longevity researcher, host of  @ultimatehumanpodcast  and co-founder of 10X Health, Gary spent over 20 years in life insurance analyzing bloodwork, biomarkers, and medical records to predict lifespan with astonishing accuracy. Realizing the system profits when people get sick, not healthy, Gary shifted his focus to proactive health, longevity, and human optimization.  Today, he helps CEOs, elite athletes, and high performers boost energy, reverse biological aging, and extend healthspan.On this episode, Gary and Mo discuss why the healthcare system waits for you to break before acting, how to transition from sick care to self-care, and which biohacks actually move the needle from sleep, oxygen, and nutrition to blood markers. They also explore why supplements are useless without testing and reveal the single most overlooked factor that accelerates aging. 0:00 Intro3:34 Leaving the Mortality Industry4:48 Purpose, Passion & Energy6:34 Bringing Longevity to the Arab World8:00 Predicting Mortality in Insurance10:07 AI, Big Data & the Future of Medicine13:34 Modern Medicine vs Root Cause17:13 Can Disease Be Reversed?19:02 Dana White24:52 “Genetics”, Food & Pharma28:13 Anxiety & ADD33:10 Why Everyone Needs a Methylation Test36:33 Gut Health & Mood40:55 Migraines & Solutions45:14 Autoimmune Disease & Rethinking the Immune System50:03 Why Root Cause Beats Medication51:00 Teaching Longevity to Children52:49 Closing Remarks

Listen in as Kristin chats with Dr Angela Kwong, a Sydney-based General Practitioner with a special interest in medically supervised weight management, about the use of GLP-1 agonists. Dr Kwong serves as the NSW State Lead for the RACGP Specific Interests Group in Obesity Management and works closely with colleagues across disciplines to improve care for people living with obesity. She is also the founder of Enlighten Me, a multidisciplinary online program that provides evidence-based, GP-led support for patients seeking weight management. The program has been recognised for its contribution to patient education and its focus on accessible, stigma-free care. Additional GLP-1 reading: 1. GLP-1 agonist role in renal protection - FLOW Trial 1a. Digestible summary of the FLOW trial 2. Current ANZCA guidelines for anaesthesia / sedation in patients using GLP-1 agonists (May 2025) 3. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity

The continuing explosion in demand for new wight-loss drugs is raising difficult questions about how society talks about weight, and how it treats people with weight loss. Professor Donal O'Shea, endocrinologist and HSE Clinical Lead for Obesity, brings Brendan up to date.

Today will be the first post in a short series discussing attempts to “calculate” the (supposed) “costs” of “ob*sity.”Before we get into any of this I want to say unequivocally that anytime we try to calculate the cost of a group of people, including and especially, to support a call for their eradication, we are going down a very bad, very wrong road. So while I will be discussing the specific issues with these calculations, please always remember that the calculations shouldn't be undertaken in the first place. Get full access to Weight and Healthcare at weightandhealthcare.substack.com/subscribe

Gugs Mhlungu is joined by Dr Fundile Nyati, Resident GP and CEO of Proactive Health Solution, exploring the rise of type 2 diabetes in children and the contributing factors such as lifestyle habits, increased indoor play, and excessive screen time, as well as how early diagnosis can help prevent the condition. 702 Weekend Breakfast with Gugs Mhlungu is broadcast on 702, a Johannesburg based talk radio station, on Saturdays and Sundays Gugs Mhlungu gets you ready for the weekend each Saturday and Sunday morning on 702. She is your weekend wake-up companion, with all you need to know for your weekend. The topics Gugs covers range from lifestyle, family, health, and fitness to books, motoring, cooking, culture, and what is happening on the weekend in 702land. Thank you for listening to a podcast from 702 Weekend Breakfast with Gugs Mhlungu. Listen live on Primedia+ on Saturdays and Sundays from 06:00 and 10:00 (SA Time) to Weekend Breakfast with Gugs Mhlungu broadcast on 702 https://buff.ly/gk3y0Kj For more from the show go to https://buff.ly/u3Sf7Zy or find all the catch-up podcasts here https://buff.ly/BIXS7AL Subscribe to the 702 daily and weekly newsletters https://buff.ly/v5mfetc Follow us on social media: 702 on Facebook: https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702 See omnystudio.com/listener for privacy information.

In this episode of MyHeart.net, cardiologist Dr. Alan Bouchard sits down with Dr. Timothy Garvey, Professor of Medicine in the Department of Nutrition Sciences at the University of Alabama at Birmingham, to discuss the evolving definition of obesity as a disease. Drawing from The Lancet's 2025 clinical framework, Dr. Garvey explains when excess adiposity begins to impair organ function, how this redefinition changes patient care, and why understanding obesity as a chronic disease is essential for preventing cardiometabolic complications.About the TeamDr. Alain Bouchard is a clinical cardiologist at Cardiology Specialists of Birmingham, AL. He is a native of Quebec, Canada and trained in Internal Medicine at McGill University in Montreal. He continued as a Research Fellow at the Montreal Heart Institute. He did a clinical cardiology fellowship at the University of California in San Francisco. He joined the faculty at the University of Alabama Birmingham from 1986 to 1990. He worked at CardiologyPC and Baptist Medical Center at Princeton from 1990-2019. He is now part of the Cardiology Specialists of Birmingham at UAB Medicine.Dr. Philip Johnson is originally from Selma, AL. Philip began his studies at Vanderbilt University in Nashville, TN, where he double majored in Biomedical and Electrical Engineering. After a year in the “real world” working for his father as a machine design engineer, he went to graduate school at UAB in Birmingham, AL, where he completed a Masters and PhD in Biomedical Engineering before becoming a research assistant professor in Biomedical Engineering. After a short stint in academics, he continued his education at UAB in Medical School, Internal Medicine Residency, and is currently a cardiology fellow in training with a special interest in cardiac electrophysiology.Medical DisclaimerThe contents of the MyHeart.net podcast, including as textual content, graphical content, images, and any other content contained in the Podcast (“Content”) are purely for informational purposes. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or heard on the Podcast!If you think you may have a medical emergency, call your doctor or 911 immediately. MyHeart.net does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Podcast. Reliance on any information provided by MyHeart.net, MyHeart.net employees, others appearing on the Podcast at the invitation of MyHeart.net, or other visitors to the Podcast is solely at your own risk.The Podcast and the Content are provided on an “as is” basis.

In the past 20 years, the rate of children and teenagers living with high blood pressure globally has nearly doubled because of a toxic combination of unhealthy diets, mass inactivity and soaring levels of obesity. That's according to a new meta analysis of data from 96 studies published in The Lancet Child and Adolescent Health journal. Joining Shane now to discuss this further is the Clinical lead on Obesity for the HSE, Dr Donal O'Shea.

In the past 20 years, the rate of children and teenagers living with high blood pressure globally has nearly doubled because of a toxic combination of unhealthy diets, mass inactivity and soaring levels of obesity. That's according to a new meta analysis of data from 96 studies published in The Lancet Child and Adolescent Health journal. Joining Shane now to discuss this further is the Clinical lead on Obesity for the HSE, Dr Donal O'Shea.

In this episode of the Gladden Longevity Podcast, Dr. Jeffrey Gladden interviews Dr. Michael Renzulli, who shares his journey into healthcare, transitioning from traditional practices to holistic approaches. They discuss the emergence of red light therapy, its scientific basis, and its applications in treating various health issues, particularly obesity and metabolic health. The conversation emphasizes the importance of innovative healing technologies and their potential to transform lives. In this conversation, Dr. Jeffrey Gladden and Dr. Mike Renzulli explore the evolution of healthcare from merely managing symptoms to addressing root causes through precision medicine. They discuss innovative approaches to weight loss, the importance of detoxification, and the role of GLP-1 medications. The conversation emphasizes the significance of body composition over weight alone, the impact of fasting, and the necessity of a systems approach to health optimization, including thyroid function and oxidative stress management. Ultimately, they advocate for personalized solutions tailored to individual needs for lasting health improvements.   For Audience Use code 'Podcast10' to get 10% OFF on any of our supplements at https://gladdenlongevityshop.com/ !    Takeaways         Dr. Renzulli's early inspiration for healthcare came from witnessing a life-saving moment.         His journey led him to explore holistic approaches after observing disillusionment in traditional doctors.         Red light therapy emerged as a significant tool in his practice, offering innovative health solutions.         The design and proximity of red light beds are crucial for effective treatment outcomes.         Different wavelengths of light have varying effects on the body, from skin rejuvenation to deeper tissue healing.         Red light therapy can enhance ATP production and reduce oxidative stress.         Integrating red light therapy with other treatments can improve metabolic health and energy levels.         Obesity is a growing epidemic, and red light therapy can play a role in weight loss.         The technology behind red light therapy is backed by numerous studies and evidence-based results.         Patients experience significant improvements in health and well-being through these innovative therapies. Patients are increasingly seeking root cause solutions rather than just symptom management.         Precision medicine offers real hope and tangible results for patients.         Weight loss strategies must focus on detoxification and cellular health.         Inflammation is a key factor in weight gain and insulin resistance.         A systematic approach to health can yield better outcomes than isolated treatments.         Body composition is a more important metric than weight alone.         GLP-1 medications can have adverse effects on muscle and bone density.         Fasting can be beneficial if done correctly, focusing on fat loss rather than muscle loss.         Precision medicine requires a deep understanding of individual genetics and biology.         A comprehensive approach to health includes monitoring thyroid function and metabolic rates.   Chapters 00:00 Introduction to Healthcare Journey 03:01 Transitioning from Traditional to Holistic Healthcare 06:12 The Rise of Red Light Therapy 08:56 Understanding Red Light Technology 11:52 The Science Behind Wavelengths and Healing 14:55 Applications of Red Light Therapy in Health 17:55 Addressing Obesity and Metabolic Health 20:50 Integrating Therapies for Optimal Health 23:45 The Shift from Symptom Management to Root Cause Healing 24:40 Real Results: The Promise of Precision Medicine 25:59 Innovative Approaches to Weight Loss and Wellness 28:50 The Science of Detoxification and Cellular Reset 31:05 Understanding Oxidative Stress and Inflammation 32:37 The Importance of Body Composition Over Weight 36:01 The Role of GLP-1 in Weight Management 38:34 Fasting and Its Impact on Body Composition 40:52 Precision Medicine: Tailoring Solutions for Individuals 42:07 Balancing Thyroid Function for Weight Loss 46:49 The Systems Approach to Health Optimization   To learn more about Dr. Renzulli: Email:  info@bioantiage.com Website: www.bioantiage.com   Reach out to us at:    Website: https://gladdenlongevity.com/     Facebook: https://www.facebook.com/Gladdenlongevity/    Instagram: https://www.instagram.com/gladdenlongevity/?hl=en     LinkedIn: https://www.linkedin.com/company/gladdenlongevity    YouTube: https://www.youtube.com/channel/UC5_q8nexY4K5ilgFnKm7naw       Gladden Longevity Podcast Disclosures Production & Independence The Gladden Longevity Podcast and Age Hackers are produced by Gladden Longevity Podcast, which operates independently from Dr. Jeffrey Gladden's clinical practice and research at Gladden Longevity in Irving, Texas. Dr. Gladden may serve as a founder, advisor, or investor in select health, wellness, or longevity-related ventures. These may occasionally be referenced in podcast discussions when relevant to educational topics. Any such mentions are for informational purposes only and do not constitute endorsements. Medical Disclaimer The Gladden Longevity Podcast is intended for educational and informational purposes only. It does not constitute the practice of medicine, nursing, or other professional healthcare services — including the giving of medical advice — and no doctor–patient relationship is formed through this podcast or its associated content. The information shared on this podcast, including opinions, research discussions, and referenced materials, is not intended to replace or serve as a substitute for professional medical advice, diagnosis, or treatment. Listeners should not disregard or delay seeking medical advice for any condition they may have. Always seek the guidance of a qualified healthcare professional regarding any questions or concerns about your health, medical conditions, or treatment options. Use of information from this podcast and any linked materials is at the listener's own risk. Podcast Guest Disclosures Guests on the Gladden Longevity Podcast may hold financial interests, advisory roles, or ownership stakes in companies, products, or services discussed during their appearance. The views expressed by guests are their own and do not necessarily reflect the opinions or positions of Gladden Longevity, Dr. Jeffrey Gladden, or the production team. Sponsorships & Affiliate Disclosures To support the creation of high-quality educational content, the Gladden Longevity Podcast may include paid sponsorships or affiliate partnerships. Any such partnerships will be clearly identified during episodes or noted in the accompanying show notes. We may receive compensation through affiliate links or sponsorship agreements when products or services are mentioned on the show. However, these partnerships do not influence the opinions, recommendations, or clinical integrity of the information presented. Additional Note on Content Integrity All content is carefully curated to align with our mission of promoting science-based, ethical, and responsible approaches to health, wellness, and longevity. We strive to maintain the highest standards of transparency and educational value in all our communications.

The U.S. government finally reopens after the longest shutdown in history — but at what cost? The CDC reports that over 42% of Americans over 20 are now obese, and a new study reveals how antidepressants are taking a serious toll on the younger generation’s sex lives.See omnystudio.com/listener for privacy information.

Medications such as Ozempic, Mounjaro and more have been popular in the media in recent years, but how can they affect menopause? In this episode, Adele unpacks the truth behind the buzz surrounding GLP-1 medications. Are they really miracle weight loss drugs for those in menopause? Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, 46, 101102. https://doi.org/10.1016/j.molmet.2020.101102   Holst, J. J., & Madsbad, S. (2016). Mechanisms of surgical control of type 2 diabetes: GLP-1 is key factor. Surgery for Obesity and Related Diseases, 12(6), 1236–1242. https://doi.org/10.1016/j.soard.2016.02.033 ____________ Check out Adele's FREE symptom assessment here: https://adelejohnstoncoaching.com/free-copy-of-our-symptom-assessment/ 12 Minute Breathwork Method: https://adelejohnstoncoaching.com/breathwork/ The Menopause Cheat Sheet: https://docs.google.com/document/d/1ka-fN6J5DJW2J3IE0Qa80zFCKFXmTs4srlnlXYBf-gA/edit?usp=sharing If you want a chat for your future success, fuel yourself here: https://calendly.com/adelejohnston/successchat Download Adele's Journey Journal here : https://adelejohnstoncoaching.com/my-journey-journal/ Enquire about 121 coaching here : https://docs.google.com/forms/d/e/1FAIpQLSfw6vrmKPE7A1eYDKQJiR9No7ZDdpfq-grBdKYjZSR-vl0Qag/viewform For extra support: Support@adelejohnstoncoaching.com ____________ From your host : Adele Johnston I'm Adele Johnston, a certified nutritionist and positive psychology coach, passionate about helping women improve their menopause health and reclaim who you are without menopause taking over. This is a time in your life where you get to feel vibrant, sexy and reclaim you again! I'm proud to work with women like you and have created a very successful proven Reclaiming You 3 STEP PROCESS to help you take back control of your body during your menopause. For more details : https://adelejohnstoncoaching.com/ To get Adele's FREE 3-step Menopause Weight Loss Guide: https://adelejohnstoncoaching.com/menopause-weight-loss-guide/

In this episode of The Pet Food Science Podcast Show, Dr. Alex German, Professor of Small Animal Medicine at the University of Liverpool, explores how veterinarians and pet nutritionists can better understand and manage obesity in dogs and cats. He explains the clinical definitions of obesity, new prevention strategies, and the future of treatment, including the potential for drug therapies. Discover practical insights to improve companion animal health. Listen now on all major platforms!“Obesity should be recognized as a clinical condition rather than simply excess fat accumulation, as it has direct consequences on health.”Meet the guest: Dr. Alex German is the Professor of Small Animal Medicine at the University of Liverpool. With a veterinary degree and PhD from the University of Bristol, his work focuses on clinical obesity medicine, ageing science, and disease prevention in pets. His research bridges veterinary internal medicine and nutrition, providing essential insights for healthier pets. Liked this one? Don't stop now — Here's what we think you'll love!Don't miss the chance to be part of the Pet Food Inner Circle!Join now and connect with leading experts in pet nutrition: https://petfoodinnercircle.com/What will you learn:(00:00) Highlight(00:54) Introduction(05:24) Obesity classification(11:51) Assessment tools(14:26) Prevention strategies(20:03) Clinical management(23:54) Future therapies(33:56) Final QuestionsThe Pet Food Science Podcast Show is trusted and supported by innovative companies like:* Trouw Nutrition* Kemin- Biorigin

Big Pharma just rewrote the rulebook in the obesity-treatment race. Pfizer has won the bidding for Metsera after a showdown with Novo Nordisk. Dan Koh and Emaad Akhtar unpack how this US$10 billion move signals a pivot into GLP-1 drugs, why Novo walked away and what it all means for investors tracking the next trillion-dollar health-tech frontier.See omnystudio.com/listener for privacy information.

What if blockbuster weight-loss drugs and a broken food system are two sides of the same story? We sit down with Dr. David Harlan—physician, researcher, and former NIH diabetes branch chief—to trace the unlikely path from the “incretin effect” to GLP-1 therapies that are transforming care for type 2 diabetes and obesity. Along the way, we ask harder questions about incentives, access, and why lifestyle still matters even when the medicine is powerful.Dr. Harlan breaks down how GLP-1 receptor agonists amplify insulin release, quiet cravings, and drive meaningful weight loss—often alongside better blood pressure, improved A1C, and fewer heart events. He explains the Gila monster connection, why weekly injections replaced multiple daily shots, and what the latest safety data actually shows. We get candid about what happens when people stop these drugs, why genetics complicate the “just try harder” narrative, and how brain chemistry shapes appetite, compulsion, and energy.Then we zoom out to the policy level: the rise of food deserts, cheap ultra-processed calories, and the paradox of publicly funding both the problem and the fix. We explore practical steps that work in the real world—SKU-controlled health savings accounts, everyday movement campaigns, healthier default options in public spaces, and community gardens and sidewalks that make active living normal again. The throughline is simple and human: use the science to help people now, and rebuild the environment so fewer need the medicine later.If you care about diabetes, obesity, prevention, or the economics shaping our plates and prescriptions, this conversation offers clarity and a path forward. Support the show by subscribing, sharing with a friend, and leaving a review with the one insight you'll apply this week.Support the showEngage the conversation on Substack at The Common Bridge!

This week on Health Matters, Courtney talks with Dr. Robert Brown, the chief of gastroenterology and hepatology at NewYork-Presbyterian and Weill Cornell Medicine, to discuss the benefits and risks of taking dietary supplements, for our liver and our overall health. Dr. Brown offers tips for deciding which supplements to take, which to avoid, and ways we can optimize our liver health. ___Dr. Robert Brown is an expert in liver diseases, including alcohol-related liver disease, which affects up to 20 percent of the population, chronic hepatitis C infection, which affects an estimated 2.4 million Americans and cirrhosis, a scarring of the liver that is the third most common disease-related cause of death in the United States. He co-founded the Center for Liver Disease and Transplantation at NewYork-Presbyterian/Weill Cornell Medical Center, a joint program with Columbia University Irving Medical Center, in 1998. Dr. Brown will continue as medical director of this program, the largest for liver transplantation in New York City.___Health Matters is your weekly dose of health and wellness information, from the leading experts. Join host Courtney Allison to get news you can use in your own life. New episodes drop each Wednesday.If you are looking for practical health tips and trustworthy information from world-class doctors and medical experts you will enjoy listening to Health Matters. Health Matters was created to share stories of science, care, and wellness that are happening every day at NewYork-Presbyterian, one of the nation's most comprehensive, integrated academic healthcare systems. In keeping with NewYork-Presbyterian's long legacy of medical breakthroughs and innovation, Health Matters features the latest news, insights, and health tips from our trusted experts; inspiring first-hand accounts from patients and caregivers; and updates on the latest research and innovations in patient care, all in collaboration with our renowned medical schools, Columbia and Weill Cornell Medicine.To learn more visit: https://healthmatters.nyp.org

How To Address Weight In A Body Positive CultureIn this episode, I sit down with Dr. Tzvi Doron, a board-certified Family and Obesity Medicine physician and lipidology expert, to unpack the middle ground between body neutrality and evidence-based obesity care.We talk about how to approach weight without shame, how weight loss impacts lipids and cardiometabolic risk, and why protecting lean mass should be your new top priority in weight management.Key TakeawaysWeight ≠ worth. But it still influences health, and that's okay to address.Ask permission first. “Is it okay if we talk about how your weight may be impacting your health?” opens the door without judgment.Protect lean mass. Resistance training + adequate protein are non-negotiable for long-term health.Obesity is a brain disease. Effective care focuses on underlying drivers, not just pounds lost.Success looks different. Better labs, more energy, improved function, and confidence count as wins.Resources MentionedEpisode 111 | HDL Good, LDL Bad — It's Not That SimpleObesity Medicine Nutrition Course: Earn 10.5 CE credits and learn how to help patients change (use code POD15 for 15% off)Connect with Dr DoronAny Questions? Send Me a MessageSupport the showConnect with Colleen:InstagramLinkedInSign up for my FREE Newsletter - Nutrition hot-topics delivered to your inbox each week. Disclaimer: This podcast is a collection of ideas, strategies, and opinions of the author(s). Its goal is to provide useful information on each of the topics shared within. It is not intended to provide medical, health, or professional consultation or to diagnosis-specific weight or feeding challenges. The author(s) advises the reader to always consult with appropriate health, medical, and professional consultants for support for individual children and family situations. The author(s) do not take responsibility for the personal or other risks, loss, or liability incurred as a direct or indirect consequence of the application or use of information provided. All opinions stated in this podcast are my own and do not reflect the opinions of my employer.

Bariatric surgery is a procedure used to manage obesity and obesity-related conditions. While studies have shown that bariatric surgery leads to significant weight loss, are there cases where it may be important to consider reversing the procedure? What would such cases look like? How effectively can bariatric surgery be reversed? To help explore those questions, host Aaron Lohr talks with Katherine Hazen, MD, a second-year endocrine fellow at the University of Rochester Medical Center. She and colleagues presented an abstract at ENDO 2025 titled, “Going Backwards as a Means of Moving Forward: Severe Hypoglycemia After Bariatric Surgery.” Show notes are available at https://www.endocrine.org/podcast/enp106 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Hear about the promise of combination therapies and dual and triple agonists in helping people with obesity lose weight and improve overall health. Credit available for this activity expires: 11/11/26Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003041?ecd=bdc_podcast_libsyn_mscpedu  

In this episode, Peter Brindley interviews Dr. Rob Bevan, past president of the CICM, about the obesity paradox in Intensive Care Units (ICUs). They discuss the surprising observation that overweight ICU patients often show better survival rates than those underweight, despite obesity's known health risks. Dr. Bevan dives into the history and the limitations of BMI as a metric and various biases that could influence the perceived obesity paradox. He also explains how classification bias, selection bias, confounding, and collider bias might skew these outcomes. The discussion touches on the importance of separating patients who are critically ill and happen to be obese from those who are in ICU primarily because of obesity-related diseases. The conversation is rooted in the upcoming textbook chapter authored by Dr. Bevan and explores obesity's broader health implications globally.

Obesity overtakes malnourishment for the first time in history in children. According to a recent article in The Economist, the amount of overweight and obese children is actually more than those who are underweight due to not getting enough food. And this is worldwide...not just in the wealthier nations. Wow...ultraprocessed food combined with sedentary lifestyles leads to poorer health outcomes. More info? Check out our website at: https://www.theadjustment.com/ or our blog at: https://www.theadjustment.com/blog/chiroblog/. Original article: https://economist.com/graphic-detail/2025/09/10/a-world-map-of-childhood-obesity

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about President Trump announcing a deal to lower the price of weight loss drugs, why iron deficiency in adults may be more common than thought, and what can be done to improve access to physicians.

With ObesityWeek yielding eye-catching amylin data and a bidding war that ran to $10 billion for Metsera, weight loss companies were center stage in biotech last week. On the latest edition of the BioCentury This Week podcast, BioCentury's analysts explained why Pfizer's victory for the start-up over European rival Novo Nordisk doesn't necessarily mean a broader U.S. policy shift against foreign acquisitions of domestic biotechs.Turning to ObesityWeek readouts, they discuss Eli Lilly's data for amylin monotherapy eloralintide, arguing that just as Lilly did with GLP-1 agonists, the company is again setting the benchmark by which all other molecules in the class will be measured.BioCentury's analysts also discuss takeaways from Washington Editor Steve Usdin's Commentary, which finds FDA in a crisis of politicized decisions, plummeting morale, and a hollowed workforce, and highlights from BioCentury's interview with gene therapy pioneer Jim Wilson as he rethinks the funding model for ultrarare disease therapies to keep his mission on track. This episode of the BioCentury This Week podcast is brought to you by Voyager Therapeutics.View full story: https://www.biocentury.com/article/657545#ObesityWeek #Amylin #GLP1 #Eloralintide #DrugMechanism #FDA #RareDisease #GeneTherapy00:01 - Sponsor Message: Voyager Therapeutics 01:53 - Pfizer Wins Metsera08:48 - Lilly's Amylin Data13:06 - Funding Ultrarare Therapies20:51 - What's Next for FDATo submit a question to BioCentury's editors, email the BioCentury This Week team at podcasts@biocentury.com.Reach us by sending a text

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about President Trump announcing a deal to lower the price of weight loss drugs, why iron deficiency in adults may be more common than thought, and what can be done to improve access to physicians.

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about President Trump announcing a deal to lower the price of weight loss drugs, why iron deficiency in adults may be more common than thought, and what can be done to improve access to physicians.

In this powerful episode, I will break down one of the biggest developments in obesity and diabetes treatment in U.S. history. Two major pharmaceutical companies - Eli Lilly and Novo Nordisk - have reached a groundbreaking agreement with the administration that will drastically reduce the prices of popular medications like Wegovy, Ozempic, and Zepbound. This pricing model could transform how obesity medications are covered, distributed, and accessed across Medicare, Medicaid, and direct-to-consumer platforms. Tune in to learn what this new deal means for patients, healthcare providers, and public health overall—and why it's being called a game changer for people struggling with obesity and related health conditions. Episode Highlights: Major price cuts announced for Wegovy, Ozempic, and Zepbound under a new federal deal   Medicare to cover obesity drugs for the first time through a five-year pilot program   Medicaid given the option to join discounted pricing starting 2026   Team Rx launches a direct-to-consumer model cutting out costly middlemen   Lower cash prices for GLP-1 medications and upcoming oral versions   Eli Lilly and Novo Nordisk to invest billions in U.S. manufacturing   Program expected to improve access, affordability, and supply of obesity and diabetes meds   Ongoing push for the Treat and Reduce Obesity Act to expand national coverage   Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH.  Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014.  In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss,  where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, "Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''. Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

The Trump administration has quietly introduced new visa guidance that could see people with diabetes, obesity or other chronic illnesses stopped at the border. Plus, in breaking fashion news, skinny jeans are officially back for 2025, but with new, comfier rules. And in headlines today, US President Donald Trump has pardoned his former personal lawyer, Rudy Giuliani and dozens of allies accused of backing the Republicans' efforts to overturn the 2020 election; Australia will pause at 11am today to mark the 107th anniversary of the armistice that ended fighting in World War I; Princess Anne spent the day in Melbourne yesterday, laying a wreath in honour of the police officers killed in Porepunkah; Robert Irwin has named a new arrival at Australia Zoo, a baby wallaby, after his Dancing With the Stars partner Witney Carson THE END BITS Check out Nothing To Wear here Support independent women's media Check out The Quicky Instagram here GET IN TOUCHShare your story, feedback, or dilemma! Send us a voice note or email us at thequicky@mamamia.com.au CREDITS Hosts: Taylah Strano & Claire Murphy Audio Producer: Lu Hill Become a Mamamia subscriber: https://www.mamamia.com.au/subscribeSee omnystudio.com/listener for privacy information.

The ACOG acknowledges that maternal obesity affects labor curves and recommends allowing more time for cervical dilation before diagnosing labor arrest in obese patients. This approach aims to avoid unnecessary interventions, such as premature cesarean delivery, which may occur if standard labor curves are strictly applied to obese women. In this episode, we will review a new study from the AJOG (08 Nov 2025) which describes labor progression and duration according to maternal body mass index, validating the need (possibly) for a BMI -based labor curve. Has there been advocates of a BMI-based labor curve? Listen in for details.1. Edwards, Sara et al. Characterizing Labor Progression and Duration According to Maternal Body Mass Index. American Journal of Obstetrics & Gynecology, Volume 0, Issue 02. Lundborg L, Liu X, Åberg K, et al. Association of Body Mass Index and Maternal Age With First Stage Duration of Labour. Scientific Reports. 2021;11(1):13843. doi:10.1038/s41598-021-93217-5.3. Kominiarek MA, Zhang J, Vanveldhuisen P, et al. Contemporary Labor Patterns: The Impact of Maternal Body Mass Index. American Journal of Obstetrics and Gynecology. 2011;205(3):244.e1-8. doi:10.1016/j.ajog.2011.06.014.4. Norman SM, Tuuli MG, Odibo AO, et al. The Effects of Obesity on the First Stage of Labor.Obstetrics and Gynecology. 2012;120(1):130-5. doi:10.1097/AOG.0b013e318259589c.

Alternate Current Radio Presents - Boiler Room - Learn to protect yourself from predatory mass mediaIn this edition of Boiler Room, Hesher is joined by Ruckus and Mystical Pharaoh for a deep-dive into the shadows behind modern headlines. The crew dissects the passing of Dick Cheney and the end of Pelosi's congressional run, exploring what these political exits reveal about the shifting American power structure. The team also examines the UPS cargo plane crash and the increasing role of automation in transportation — leading into a conversation about “house robots,” digital surveillance, and the quiet normalization of cultural vampires feeding on convenience.Featuring: Bryan ‘Hesher' McClain, Adam ‘Ruckus' Clark and Mystical PharaohWebsite: https://alternatecurrentradio.comSupport: https://alternatecurrentradio.com/support/Merch: https://alternate-current-radio.creator-spring.com/

The White House has struck a deal with two more drugmakers: Eli Lilly and Novo Nordisk. Centers for Medicare and Medicaid Services administrator Dr. Mehmet Oz discusses the administration's plan to make GLP-1s more affordable for Americans. Tesla shareholders voted to approve Elon Musk's $1 trillion pay package, as long as he reaches their lofty goals for the company. Musk biographer Walter Isaacson discusses the plan of milestones and Musk's history of exceeding investor expectations. Plus, U.S. airlines are beginning to cancel flights to manage shutdown-strained staffing of air traffic controllers, and Warren Buffett issued a warning on AI.  Dr. Mehmet Oz - 21:43Walter Isaacson - 38:56 In this episode:Dr. Mehmet Oz, @DrOzJoe Kernen, @JoeSquawk Andrew Ross Sorkin, @andrewrsorkinKatie Kramer, @Kramer_Katie Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Program notes:0:37 An oral med for obesity1:37 Five to 10% stopped medication2:35 Need head-to-head trials with injectable3:00 Stem cell infusion after MI and heart failure4:01 Reduced heart failure in recipients5:01 Twice as many in the control arm6:01 Moving past BMI in predicting atherosclerosis7:01 Especially in overweight but not obese8:01 Almost 3000 participants in Brazil8:25 Blood samples precede MS9:04 Seen seven years beforehand10:02 Twin studies and relatives11:03 Way to intervene earlier11:15 Applaud OpenAI13:00 End

In this episode of Food Chained, Vasa interviews Nicky Seaman, founder of Freestyle Snacks, discussing her journey in the food industry, the creation of her innovative snack products, and the challenges and successes she faced during the pandemic. Nicky shares insights on retail strategies, the importance of packaging, and her latest product launch of pickle chips. The conversation also explores personal growth, the importance of following through on commitments, and the future of food trends. NOTE: The audio is a bit spotty, but Nikki drops some amazing information. WHAT WE GO OVER:The idea behind Freestyle Snacks Scrappy, winning retail strategiesHow Nicky's experience at Whisps helped her launch her own brandWhat drove the recent launch of pickle chips?The importance of packaging in attracting new consumersHow to leverage exclusivity with retailersNicky's superpowerGrowing trend of pickles in the food industry.Growth during the holidaysCONNECT WITH US:Connect with Vasa on LinkedInConnect with Nikki on LinkedInPerfy's websiteCPGSPN by Growthbuster, a CPG newsletter with a sports themeCheck out Freestyle SnacksSPONSOR:Food Chained is a Perfy podcast brought to you by Growthbuster. Growthbuster is a team of creatives and strategists that help food & beverage brands grow. Check out Growthbuster's newsletter, CPGSPN here. 

In this episode of Food Chained, Vasa interviews Fred Hart, founder of Hart Brands, discussing his journey from growing up in Hawaii to becoming a prominent figure in branding and design within the consumer goods industry. Fred shares insights from his agency experience, the importance of trade shows, and the evolving landscape of design trends. The conversation also touches on the significance of nostalgia in branding and the challenges faced by legacy brands. Fred offers valuable insights on agency selection and the crucial role of packaging in consumer engagement.TAKEAWAYS:Fred Hart emphasizes the importance of learning from mistakes in a supportive environment.The design journey often starts from personal passions, such as sports and sneakers.Agency experience can accelerate learning and growth in the branding field.Independent consulting allows for flexibility and creativity in project work.Trade shows are vital for understanding industry trends and consumer behavior.Design trends are shifting towards more original and restrained aesthetics.Nostalgia plays a significant role in branding, but it must be balanced with modernity.Brands need to differentiate themselves in a crowded market to stand out.The importance of cohesive branding across all consumer touchpoints is critical.Legacy brands have opportunities for reinvention through strategic design.CONNECT WITH US:Connect with Vasa on LinkedInConnect with Fred on LinkedInPerfy's websiteCPGSPN by Growthbuster, a CPG newsletter with a sports themeCheck out Hart BrandsSPONSOR:Food Chained is a Perfy podcast brought to you by Growthbuster. Growthbuster is a team of creatives and strategists that help food & beverage brands grow. Check out Growthbuster's newsletter, CPGSPN here. 

Hour 4 Audio from WGIG-AM in Brunswick, GA

AKA, "Learning to Fly."  AKA AKA, "The Transgender Panda Show."

BEST OF - National Correspondent Rory O'Neill reports on the government shutdown's ripple effects as the FAA orders a 10% air traffic reduction causing widespread flight cancelations, plus President Trump's Oval Office announcement on obesity drugs. Nancy Pelosi announces her retirement from Congress—White House Correspondent Jon Decker discusses her legacy and Trump's reaction. Also, October layoffs hit a 22-year high while Americans gear up to spend $1 trillion on holiday shopping for the first time.See omnystudio.com/listener for privacy information.

We start with a federal judge's ruling on coverage for food stamp benefits this month amid a government shutdown. The Supreme Court clears way for President Donald Trump's transgender passport policy. A verdict has been reached in a lawsuit filed by a former Virginia teacher shot by her student. We'll break down the White House's deals that promise to lower prices for some weight loss drugs. Plus, the latest on a case challenging federal agents' crackdown tactics in Chicago. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Cardiologist Dr. Kim Connelly joins us on Diabetes Primetime to explain the powerful connection between inflammation, obesity, and heart disease. He tells us why understanding this link is SO important, and the steps we need to take today for our health.For helpful resources, interviews with diabetes experts, and more, visit our website here: diabeteswhattoknow.com.All content of this channel is owned by What To Know, LLC. and is protected by worldwide copyright laws. You may download content only for your personal use (i.e., for non-commercial purposes) but no modification or further reproduction of the content is permitted. The content may otherwise not be copied or used in any way.Diabetes - What to Know ©️ 2025The medical information in Diabetes - What To Know's content is provided as an information resource only. The content is not in any way intended to be nor should you rely on it as a substitute for professional medical evaluation, diagnosis, advice and treatment.#diabetes #diabetesmanagement #t2d #t2diabetes #type2 #type2diabetes #healthy #diabetescare #weightmanagement

Trump unveils deal to expand coverage and lower costs on obesity drugs Wegovy and Zepbound. AP's Lisa Dwyer reports.

Earnings are filtering in, and companies are seeing a tale of two very different consumers. The group raising concerns about their customer base, and the names not seeing any slowdown. Plus Novo and Eli Lilly nearing a deal with the White house to lower obesity drug prices. What it means for the space, and how it could change medicare coverage of the weight loss drugs.Fast Money Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Did you know your sleep habits could be affecting your weight? Join us with Dr. Michael Mak as he explains the powerful connection between sleep and obesity, why sleep is essential for overall health, and tips for getting a better night's rest.The medical information in this podcast is provided as an information resource only. It is not in any way intended to be nor should you rely on it as a substitute for professional medical evaluation, diagnosis, advice and treatment.This episode was sponsored by Novo Nordisk. It was created independently by My Weight - What to Know with no influence from Novo Nordisk.

Join endocrine expert Dr. David Lieb as he moderates a discussion with Dr. Karl Nadolsky, Chair of the AACE Obesity Algorithm, and Dr. Timothy Garvey, Vice Chair, as they review the 2025 AACE Algorithm for the Evaluation and Treatment of Adults with Obesity/Adiposity-Based Chronic Disease and highlight key updates since 2016. The experts discuss advances in pharmacotherapy, the evolution of complication-centric and person-centered care, and strategies to reduce weight bias in clinical practice. They also share guidance on individualizing therapy and look ahead to the future of obesity medications as new treatments emerge.

Stock market update for November 5, 2025.Follow us on Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@therundowndaily⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠This video is for informational purposes only and reflects the views of the host and guest, not Public Holdings or its subsidiaries. Mentions of assets are not recommendations. Investing involves risk, including loss. Past performance does not guarantee future results. For full disclosures, visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Public.com/disclosures⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Bonus Episode for Nov. 4. The weight-loss-drug arms race is only heating up, as Novo Nordisk attempts to snatch drugmaker Metsera away from Pfizer. But can either company compete with Zepbound seller Eli Lilly? WSJ reporter Peter Loftus discusses what earnings from Big Pharma, including AbbVie, Bristol Myers Squibb and Merck, say about the future of the industry and how companies are responding to President Trump's drug-pricing plans, including TrumpRx. WSJ Heard on the Street columnist David Wainer hosts this special bonus episode of What's News in Earnings, where we dig into companies' earnings reports and analyst calls to find out what's going on under the hood of the American economy. Sign up for the WSJ's free Markets A.M. newsletter. Further Reading: Novo Nordisk Sweetens Offer for Metsera - WSJ Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal Why Pfizer Can Still Prevail in the Obesity Fight With Novo Nordisk The Day Pharma's Weight-Loss Gold Rush Intensified Pfizer Profit Falls Amid Lower Covid-19 Drug Demand Novo Nordisk Seeks to Outmuscle Pfizer With $9 Billion Bid for Metsera Novo Nordisk to Shake Up Board After Obesity-Market Challenges Mounjaro Powers Eli Lilly to Bumper Quarter of Earnings AbbVie Lifts Profit Outlook as Sales Rise Bristol Myers Squibb Profit Soars, Raises Revenue Guidance Merck Profit Rises on Strong Keytruda Demand GSK Lifts Guidance After Specialty Medicines Boost Sales Novartis Expects to Ride Out Patent Losses With Sales, Profit Growth Ahead Biogen Cuts Full-Year Earnings Guidance, Despite Third-Quarter Profit Rise J&J Lifts Full-Year Sales Outlook, Fueled by Pharma, Med-Device Gains Learn more about your ad choices. Visit megaphone.fm/adchoices

Send us a textTemple Stewart is a returning guest on our show! Be sure to check out her first appearance on episode 528 of Boundless Body Radio!Temple Stewart is a Registered Dietitian, Certified Personal Trainer, and Health Behavior Change Specialist. Temple played D1 soccer at the University of Tennessee-Martin, where she earned her degree in Dietetics. Her internship was completed at the VA Medical Center in Bay Pines, FL.The decision to become an RDN stemmed from Temple's lifelong involvement in sports and her fascination with how proper fueling of the body affects performance. However, during her college years, she developed an unhealthy relationship with food, using food rules and diets as punishment or for comfort. This experience led her to delve into learning about food and its impact on the body, ultimately leading her to choose a career as a Registered Dietitian.Her interest in nutrition deepened after being diagnosed with Hashimoto's Thyroiditis and PCOS, further emphasizing the importance of treating the body with proper nutrition. Temple enjoys outdoor activities, and resides in the greater Phoenix, AZ area with her husband and their two kiddos!Find Temple at-https://www.templetheketonutritionist.com/IG- @the.ketogenic.nutritionistFB- @templestewartrdnYT- @The.Ketogenic.NutritionistPodcast- The Ketogenic Nutritionist with Temple Stewart, Registered DieticianFind Boundless Body at- myboundlessbody.com Book a session with us here!

Daylight Savings Time changeover health myths busted; A doctor breaks her ankle and is billed $64,000 in uncovered expenses; Vitamin D shields life-prolonging telomeres, may help depression; The vaunted DASH Diet for hypertension faces off against low-carb alternative; The critical first 1000 days after conception—early life sugar avoidance yields major later life health dividends; Do you really need hot water to disinfect your hands?

Resources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Find Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________Get the latest buzz on GLP-1 therapies and the future of metabolic medicine! This episode provides an in-depth look at what's coming out of Obesity Week in Atlanta, GA, featuring expert insights from Dave Knapp from On the Pen.Key Topics & Breakthroughs:Corporate Battle for Biotech: We break down the surprise counteroffer by Novo Nordisk to acquire Metsera, the obesity biotech company that Pfizer had recently announced it was buying, setting the stage for a major pharmaceutical turf war.Pipeline Watch: Dive into the plethora of new therapies in current clinical trials, including the latest developments from Viking Therapeutics and the push for Oral GLP-1s.GLP-1's New Frontier: Discover the groundbreaking research on GLP-1's potential role in treating alcohol and narcotics addictions. We also discuss Brenipatide and its surprising dual focus on alcohol abuse and asthma.Tune in for a comprehensive review of the medications, mergers, and clinical trials shaping the next generation of weight loss and metabolic treatments.______________________________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 for $ OFF______________________________________________________________________Join this channel to get access to perks:   / @theplussidez______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1StoriesSend us Fan Mail! GetClaimable.com/PlusSideZ to appeal your GLP-1 Insurance Denails and use code PlusSideZ to save! Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==

Dr. Wallach discusses the root causes of critical health issues pulling from years of research. Our world is broken, built on layer after of layer of distortion and lies. Modern medicine is one of the worst in promoting lies, leading people to trust in doctors and institutions whose track record is one of failure. Dr. Wallach uses many examples to expose the brokenness we accept as normal, ultimately pointing to the root cause of so many health issues: lack of mineralization in the body.  #BardsFM_HealthAndWellness #MineralizationOfTheBody #BodyTemplePerfectDesign Bards Nation Health Store: www.bardsnationhealth.com BardsFM CAP, Celebrating 50 Million Downloads: https://ambitiousfaith.net Morning Intro Music Provided by Brian Kahanek: www.briankahanek.com MYPillow promo code: BARDS Go to https://www.mypillow.com/bards and use the promo code BARDS or... Call 1-800-975-2939.  White Oak Pastures Grassfed Meats, Get $20 off any order $150 or more. Promo Code BARDS: www.whiteoakpastures.com/BARDS Windblown Media 20% Discount with promo code BARDS: windblownmedia.com Founders Bible 20% discount code: BARDS >>> TheFoundersBible.com Mission Darkness Faraday Bags and RF Shielding. Promo code BARDS: Click here EMPShield protect your vehicles and home. Promo code BARDS: Click here EMF Solutions to keep your home safe: https://www.emfsol.com/?aff=bards Treadlite Broadforks...best garden tool EVER. Promo code BARDS: TreadliteBroadforks.com No Knot Today Natural Skin Products: NoKnotToday.com Health, Nutrition and Detox Consulting: HealthIsLocal.com Destination Real Food Book on Amazon: click here Images In Bloom Soaps and Things: ImagesInBloom.com Angeline Design: AngelineDesign.com DONATE: Click here Mailing Address: Xpedition Cafe, LLC Attn. Scott Kesterson 591 E Central Ave, #740 Sutherlin, OR  97479

EP.236: Check Out LVLUP: Head to https://lvluphealth.com/DRTYNA and use code DRTYNA at checkout to get 15% off your order sitewide.  Kyal Van Der Leest from LVLUP is back on the show! He's a total mad genius when it comes to peptides, metabolism, and optimizing the systems that keep you strong and healthy. You all loved our last conversation, and this one takes things even deeper. We're talking all things GLP-1s and how to actually support your body while using them. There's a lot more to it than just weight loss. We cover gut health, liver and biliary function, hormones, thyroid, muscle preservation, and longevity pathways. We also touch on how to avoid muscle loss, how to cycle peptides properly, and why supporting your mitochondria and detox systems is key when you're microdosing or using GLP-1s for any goal. Topics Discussed: → What are the best ways to support your body while using GLP-1s? → How do peptides improve gut and liver health? → Can GLP-1s cause muscle loss, and how can you prevent it? → What supplements help balance hormones during weight loss? → How do you safely cycle peptides for longevity and performance? Sponsored By: → Puori | Go to https://puori.com/drtyna and use code DRTYNA to get 20% off → Timeline | Head to https://timeline.com/DRTYNA and get 20% off with code DRTYNA → Cozy Earth | Black Friday has come early at https://CozyEarth.com! Right now, you can stack my code DRTYNA on top of their sitewide sale, giving you up to 40% off in savings. These deals won't last, so start your holiday shopping today!  → VivaRays | Go to https://VivaRays.com and use code DRTYNA for a special discount. On This Episode We Cover:  → 00:00:00 - Introduction → 00:03:36 - Microdosing GLP-1s → 00:05:43 - GLP-1 side effects → 00:08:17 - Leaky gut & IBS → 00:17:26 - SIBO & histamine → 00:24:32 - Iron & thyroid → 00:32:39 - TUDCA support → 00:36:46 - Obesity & metabolism → 00:38:35 - Gut health & pain → 00:41:18 - Dr. Tyna's picks → 00:44:48 - Muscle loss → 00:46:08 - The science of weight loss → 00:53:04 - Longevity tools → 00:56:57 - Body recomposition → 00:58:46 - Cycling peptides → 01:05:16 - PEA benefits Dr Tyna's LVLUP Favorites:  Use code DRTYNA at checkout to get 15% off your order sitewide.  → TUDCA → ULTIMATE GI REPAIR → BPC-157 → TOTAL RECOMP → PEA → LONGEVITY  → Grab Dr. Tyna's FREE GLP1 Intro Course: https://www.drtyna.com/ozempicuncovered Further Listening:  → EP. 200 | Peptides 101: Unlock Optimized Gut, Brain and Recovery | Kyal Van Der Leest of LVLUP Check Out LVLUP: → Head to https://lvluphealth.com/DRTYNA and use code DRTYNA at checkout to get 15% off your order sitewide.  Disclaimer: Information provided in this podcast is for informational purposes only. This information is NOT intended as a substitute for the advice provided by your physician or other healthcare professional, or any information contained on or in any product. Do not use the information provided in this podcast for diagnosing or treating a health problem or disease, or prescribing medication or other treatment. Always speak with your physician or other healthcare professional before taking any medication or nutritional, herbal or other supplement, or using any treatment for a health problem. Information provided in this blog/podcast and the use of any products or services related to this podcast by you does not create a doctor-patient relationship between you and Dr. Tyna Moore. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent ANY disease.

  Headlines: – Welcome to Mo News (02:00) – Hurricane Melissa Makes Historic Landfall in Jamaica As Category 5 Storm (05:40) – US Kills 14 In Strikes On Alleged Drug Boats in Pacific, In Deadliest Maritime Attacks Yet (09:00) – Netanyahu Orders ‘Forceful' Strikes on Gaza After Hamas Breaks Ceasefire (15:20) – Mass Civilian Killings Reported In Sudanese City Seized By Paramilitary Group (19:00) – Texas Sues Tylenol Makers, Claiming They Hid Autism Risks (22:30) – U.S. Obesity Rates Fall As Record Number Of Americans Take GLP-1 Injectables (25:20) – Francis Ford Coppola Forced To Sell Prized Watches After His Movie Bombs (27:10) – On This Day In History (28:20) Thanks To Our Sponsors:  – ⁠LMNT⁠ - Free Sample Pack with any LMNT drink mix purchase –⁠ Industrious⁠ - Coworking office. 50% off day pass | Promo Code: MONEWS50 – Incogni - 60% off an annual plan| Promo Code: MONEWS – Factor Meals – 50% your first box plus free shipping | Promo Code: monews50off – Monarch Money - 50% off your first year | Promo Code: MONEWS – BetterHelp – 10% off your first month